$1.390
-0.901 (-64.81%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AARD Prediction & Forecast by Similar Chart Analysis
Alphio's AARD stock price prediction model matches the current Aardvark Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.40 (+0.44%). The 1-week path is $1.41 (+1.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aardvark Therapeutics, Inc. Stock?
Aardvark Therapeutics is not a good buy right now due to significant financial losses and regulatory challenges. The current price is $1.39, with a staggering 89.46% year-to-date decline. The RSI is at 13.033, indicating extreme oversold conditions, but the overall financial health is concerning with a net loss of $14.4 million reported in Q2 2026. The main risk is the FDA's clinical hold on ARD-101, which has led to a lack of clarity on future development and investor confidence.
AARD stock price ended at $1.39 on Friday, after losing -64.81%
Aardvark Therapeutics, Inc. (AARD) last closed at $1.39, losing -64.81%. These facts feed the 1-day and 1-week AARD price prediction above.
Forecast Drivers
Aardvark Therapeutics, Inc. (AARD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AARD, ranked by similarity.
Seasonality analysis for AARD
Historically the probability of a positive October return for AARD is 25.00%. January offers the highest probability of a positive month at 90.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AARD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $12.68 | $12.93 | $13.14 | +830.10% |
| Nov 2026 | $10.40 | $11.52 | $12.99 | +728.61% |
| Dec 2026 | $10.79 | $11.38 | $11.52 | +718.72% |
In 2026, Aardvark Therapeutics, Inc. (AARD) is projected to range from $10.40 to $13.14.
Aardvark Therapeutics, Inc. 2026 monthly forecast
In Oct 2026, Aardvark Therapeutics, Inc. is projected to average $12.93, with a low of $12.68 and high of $13.14.
In Nov 2026, Aardvark Therapeutics, Inc. is projected to average $11.52, with a low of $10.40 and high of $12.99.
In Dec 2026, Aardvark Therapeutics, Inc. is projected to average $11.38, with a low of $10.79 and high of $11.52.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.